(XPEV) Xpeng - Overview

Exchange: NYSE • Country: China • Currency: USD • Type: Common Stock • ISIN: US98422D1054

Stock: Electric Sedan, Electric SUV, Electric MPV, Electric Coupe, Smart Platform

Total Rating 26

Risk 32

Buy Signal -0.95

Auto Manufacturers » Automobile Manufacturers
Age: 5.4y

Market Cap: 17,152m
Avg Trading Vol: 130M USD

ATR: 4.22%
Peers RS (IBD): 33.33

EPS (Earnings per Share)

EPS CAGR: 13.96%
EPS Trend: 83.8%

Last SUE: -0.09
Qual. Beats: 0

Revenue

Rev. CAGR: 26.04%
Rev. Trend: 71.5%

Last SUE: 0.00
Qual. Beats: 0

Risk 5d forecast
Volatility	61.5%
Relative Tail Risk	-5.90%

Reward TTM
Sharpe Ratio	0.48
Alpha	6.58

Character TTM
Beta	0.877
Beta Downside	0.640

Drawdowns 3y
Max DD	71.65%
CAGR/Max DD	0.28

Description: XPEV Xpeng December 19, 2025

XPeng Inc. (NYSE:XPEV) is a Chinese EV manufacturer that designs, builds, and sells a range of smart electric vehicles, including the P7/P7i sports sedan, G9 and G6 SUVs, the X9 seven-seat MPV, the MONA M03 hatchback coupe, and the performance-oriented P7+. The firm also develops the XOS Tianji in-car operating system, its proprietary SEPA 2.0 vehicle platform, and offers a suite of services such as supercharging, maintenance, financing, and insurance technology support. Founded in 2015 and headquartered in Guangzhou, XPeng operates primarily in the People’s Republic of China.

Recent data shows XPeng delivered roughly 30,000 vehicles in Q3 2024, a 45% year-over-year increase driven by strong demand for its G9 SUV and the newly launched MONA M03. The company’s cash balance stood at about $5.3 billion at the end of the quarter, providing runway for continued R&D, which now consumes roughly 12% of revenue. A key macro driver is China’s ongoing NEV subsidy program and tightening emission standards, which are expanding the addressable market for premium electric sedans and SUVs.

For deeper metrics and valuation insights, you might explore ValueRay’s XPEV dashboard.

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income: -2.85b TTM > 0 and > 6% of Revenue
FCF/TA: -0.05 > 0.02 and ΔFCF/TA -2.74 > 1.0
NWC/Revenue: 9.05% < 20% (prev 31.59%; Δ -22.54% < -1%)
CFO/TA -0.02 > 3% & CFO -2.01b > Net Income -2.85b
Net Debt/EBITDA: error (EBITDA <= 0)
Current Ratio: 1.12 > 1.5 & < 3
Outstanding Shares: last quarter (952.7m) vs 12m ago -49.54% < -2%
Gross Margin: 17.08% > 18% (prev 0.11%; Δ 1697 % > 0.5%)
Asset Turnover: 80.77% > 50% (prev 49.47%; Δ 31.30% > 0%)
Interest Coverage Ratio: -5.53 > 6 (EBITDA TTM -2.01b / Interest Expense TTM 553.2m)

Altman Z'' -1.87

A: 0.06 (Total Current Assets 59.95b - Total Current Liabilities 53.57b) / Total Assets 98.31b
B: -0.44 (Retained Earnings -43.13b / Total Assets 98.31b)
C: -0.04 (EBIT TTM -3.06b / Avg Total Assets 87.37b)
D: -0.60 (Book Value of Equity -41.08b / Total Liabilities 68.32b)
Altman-Z'' Score: -1.87 = D

Beneish M -3.17

DSRI: 0.53 (Receivables 4.57b/4.59b, Revenue 70.57b/37.81b)
GMI: 0.67 (GM 17.08% / 11.45%)
AQI: 0.87 (AQ_t 0.23 / AQ_t-1 0.26)
SGI: 1.87 (Revenue 70.57b / 37.81b)
TATA: -0.01 (NI -2.85b - CFO -2.01b) / TA 98.31b)
Beneish M-Score: -3.17 (Cap -4..+1) = AA

What is the price of XPEV shares?

As of February 02, 2026, the stock is trading at USD 17.98 with a total of 6,256,087 shares traded.
Over the past week, the price has changed by -4.31%, over one month by -11.99%, over three months by -23.85% and over the past year by +14.60%.

Is XPEV a buy, sell or hold?

Xpeng has received a consensus analysts rating of 4.21. Therefore, it is recommended to buy XPEV.

StrongBuy: 14
Buy: 7
Hold: 6
Sell: 1
StrongSell: 0

What are the forecasts/targets for the XPEV price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	28.2	56.9%
Analysts Target Price	28.2	56.9%
ValueRay Target Price	16.8	-6.5%

XPEV Fundamental Data Overview February 02, 2026

Market Cap CNY = 119.23b (17.15b USD * 6.951 USD.CNY)
P/E Forward = 40.6504
P/S = 0.243
P/B = 4.1128
Revenue TTM = 70.57b CNY
EBIT TTM = -3.06b CNY
EBITDA TTM = -2.01b CNY
Long Term Debt = 6.42b CNY (from longTermDebt, last quarter)
Short Term Debt = 23.23b CNY (from shortTermDebt, last quarter)
Debt = 34.70b CNY (from shortLongTermDebtTotal, last quarter)
Net Debt = 17.17b CNY (from netDebt column, last quarter)
Enterprise Value = 119.23b CNY (119.23b + Debt 34.70b - CCE 34.70b)
Interest Coverage Ratio = -5.53 (Ebit TTM -3.06b / Interest Expense TTM 553.2m)
EV/FCF = -26.85x (Enterprise Value 119.23b / FCF TTM -4.44b)
FCF Yield = -3.72% (FCF TTM -4.44b / Enterprise Value 119.23b)
FCF Margin = -6.29% (FCF TTM -4.44b / Revenue TTM 70.57b)
Net Margin = -4.04% (Net Income TTM -2.85b / Revenue TTM 70.57b)
Gross Margin = 17.08% ((Revenue TTM 70.57b - Cost of Revenue TTM 58.52b) / Revenue TTM)
Gross Margin QoQ = 20.14% (prev 17.33%)
Tobins Q-Ratio = 1.21 (Enterprise Value 119.23b / Total Assets 98.31b)
Interest Expense / Debt = 0.29% (Interest Expense 99.3m / Debt 34.70b)
Taxrate = 21.0% (US default 21%)
NOPAT = -2.42b (EBIT -3.06b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.12 (Total Current Assets 59.95b / Total Current Liabilities 53.57b)
Debt / Equity = 1.16 (Debt 34.70b / totalStockholderEquity, last quarter 29.99b)
Debt / EBITDA = -8.56 (negative EBITDA) (Net Debt 17.17b / EBITDA -2.01b)
Debt / FCF = -3.87 (negative FCF - burning cash) (Net Debt 17.17b / FCF TTM -4.44b)
Total Stockholder Equity = 30.58b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.26% (Net Income -2.85b / Total Assets 98.31b)
RoE = -9.33% (Net Income TTM -2.85b / Total Stockholder Equity 30.58b)
RoCE = -8.27% (EBIT -3.06b / Capital Employed (Equity 30.58b + L.T.Debt 6.42b))
RoIC = -4.79% (negative operating profit) (NOPAT -2.42b / Invested Capital 50.47b)
WACC = 7.14% (E(119.23b)/V(153.92b) * Re(9.15%) + D(34.70b)/V(153.92b) * Rd(0.29%) * (1-Tc(0.21)))
Discount Rate = 9.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -28.59%
Fair Price DCF = unknown (Cash Flow -4.44b)
EPS Correlation: 83.84 | EPS CAGR: 13.96% | SUE: -0.09 | # QB: 0
Revenue Correlation: 71.46 | Revenue CAGR: 26.04% | SUE: -0.00 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.30 | Chg30d=+0.533 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=2.61 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+357.7% | Growth Revenue=+40.2%

Additional Sources for XPEV Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle